All information cancer patients need to know!
Cancer OK is for patients suffering from cancer.
Created by professional oncology medical staff at Asan Medical Center in Seoul
It is a customized ‘cancer information’ platform for each stage and stage of treatment, providing reliable ‘cancer treatment information’.

Colon cancer, lung cancer, anticancer drugs, radiation therapy, targeted anticancer drugs, immune anticancer drugs, clinical trials, cancer rehabilitation, cancer nutrition...

There is so much information related to cancer, I don't know which one is right for me, and the explanations from the medical staff in charge of my disease are so lacking.
Am OK is a service that seeks to bridge the gap between the excess and lack of information.

A pilot service will begin with information on ‘colon cancer’ and ‘lung cancer’, and other cancer information will be added in the future.

We will always provide better ‘cancer treatment information’ to help cancer patients and their guardians.

[Am OK menu composition]

ㅇMy customized information
: ‘Cancer OK’ provides customized ‘cancer information’.
Targeting lung cancer and colon cancer
We provide customized information based on cancer type, stage, and treatment journey.

ㅇAI chatbot consultation
: ‘AmOK’ is a cancer-specialized AI chatbot solution that provides information that is actually helpful to patients.
Can I drink coffee? Can I eat raw fish?
Ask ‘Dr. Baro’, an AI chatbot specializing in cancer!

ㅇAsk 1:1 questions
: You can ask any questions you have about cancer treatment to the medical staff at Asan Medical Center.

ㅇRecommended video
: You can watch videos of information that cancer patients need to know.

ㅇInterpretation of test results
: We interpret test results filled with difficult medical jargon using AI technology developed by professional medical staff.

ㅇOncology specialist column
: Discover supportive and helpful stories from oncology specialists.

ㅇNew drug clinical information
: We provide information on new drug clinical trials that you can participate in by cancer type.